Study: NCT02140255

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Description: Chosen by the site investigator and dosed according to World Health Organization (WHO) or individual country or local standard guidelines.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Description: Chosen by the site investigator and dosed according to World Health Organization (WHO) or individual country or local standard guidelines.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nevirapine (NVP)
Description: Administered orally. Dosed according to study step/participant's age/participant's weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nevirapine (NVP)
Description: Administered orally. Dosed according to study step/participant's age/participant's weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nevirapine (NVP)
Description: Administered orally. Dosed according to study step/participant's age/participant's weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nevirapine (NVP)
Description: Administered orally. Dosed according to study step/participant's age/participant's weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nevirapine (NVP)
Description: Administered orally. Dosed according to study step/participant's age/participant's weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nevirapine (NVP)
Description: Administered orally. Dosed according to study step/participant's age/participant's weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nevirapine (NVP)
Description: Administered orally. Dosed according to study step/participant's age/participant's weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lopinavir/Ritonavir (LPV/r)
Description: Administered orally. Dosed according to study step and participant's age.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lopinavir/Ritonavir (LPV/r)
Description: Administered orally. Dosed according to study step and participant's age.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Raltegravir (RAL)
Description: Administered orally. Dosed according to study step and participant's age.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Raltegravir (RAL)
Description: Administered orally. Dosed according to study step and participant's age.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Raltegravir (RAL)
Description: Administered orally. Dosed according to study step and participant's age.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Raltegravir (RAL)
Description: Administered orally. Dosed according to study step and participant's age.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Raltegravir (RAL)
Description: Administered orally. Dosed according to study step and participant's age.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VRC01
Description: 40 mg/kg administered subcutaneously.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DTG
Description: Administered orally. Dosed according to participant's weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VRC07-523LS
Description: 40 mg/kg administered subcutaneously.